Compound Detail
CHEMBL3304960
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL3304960 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | UFRCIKMHUAOIAT-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
186.3
MW (Da)
1.98
ALogP
1
HBA
2
HBD
41.8
PSA (Ų)
0.65
QED
0
Ro5 Violations
0
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 4.17
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Nuclear receptor subfamily 2 group E member 1 CHEMBL1961788 | EC50 | 4.17 | 4.17 | 67000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Nuclear receptor subfamily 2 group E member 1 | EC50 | = | 67000.0 | nM | 4.17 | Agonist activity at in human TLX LBD expressed in human HEK293T cells coexpressi... | 34115934 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34115934 | 10.1021/acs.jmedchem.1c00733 | Nuclear receptor subfamily 2 group E member 1 | 7 |
Data from ChEMBL 36 via Core Engine